HealthTzield: US approves expanded use of type 1 diabetes drug
- Updated 5 hours ago
The US Food and Drug Administration said on Friday it has approved the expanded use of Sanofi’s type 1 diabetes injection in children aged 8 to 17 years who were recently diagnosed with stage 3 of the condition. The FDA had first approved the drug, Tzield, in 2022 to delay the progression of type 1 […]
